Lọc theo
Type 2 diabetes (T2D) patients receiving a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) concomitantly appear to be at lower risk of dementia compared with those receiving a GLP-1 RA or SGLT-2i monotherapy, according to a study.
Intracranial abscesses in paediatric patients, although rare, need intensive multidisciplinary care, suggests a study, noting significant heterogeneity in current treatment strategies.
Researchers from the Chinese University of Hong Kong (CUHK) have developed a novel molecule, BB56, which can potentially serve as a lead compound for the development of new drugs for neuroinflammatory disorders.
A study from Singapore shows the potential of a virtual reality (VR)-based cognitive–motor dual-task training (CDTT) programme to improve gait performance in functionally independent older adults with mild cognitive impairment (MCI).
Các nhà nghiên cứu từ Trường Y tế Công cộng, Đại học Hồng Kông (HKU) cho thấy thái cực quyền không thua kém liệu pháp nhận thức – hành vi cho bệnh mất ngủ (CBT-I) trong việc duy trì lợi ích, giúp cải thiện ở tháng thứ 15, trên người trung niên và cao tuổi bị mất ngủ mạn tính.
A hearing aid intervention does little to reduce the incidence of dementia-level impairment in older adults with coexisting hearing loss and mild cognitive impairment (MCI), as shown in the CHOICE trial.
New drug applications approved by US FDA as of 16-30 September 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Individuals with hypertensive disorders of pregnancy (HDP) may be at increased risk of dementia, as suggested in a retrospective cohort study.
Use of statins is associated with a lower incidence of remote seizures following a first status epilepticus event, according to a retrospective study.
Theo một nghiên cứu đoàn hệ hồi cứu trình bày tại Hội nghị Quốc tế của Hiệp hội Alzheimer (AAIC) 2026, việc sử dụng thuốc đồng vận thụ thể peptide-1 giống glucagon (GLP-1RA) cho thấy khả năng làm giảm nguy cơ tử vong do mọi nguyên nhân ở bệnh nhân sa sút trí tuệ.